Abstract
Human biomonitoring results can be used to evaluate prior metals exposures but the data production must adhere to rigorous scientific standards including validation of the analytical method and calculation of the methods uncertainty. The whole procedure is often perceived as a difficult and time-consuming task. The aim of this paper was to in house validate a sector field inductively coupled plasma mass spectrometry-based method and to speed up the calculation of measurements uncertainty in the monitoring of As, Be, Cd, Co, Cr, Hg, Ir, Mn, Mo, Ni, Pb, Pd, Pt, Rh, Sb, Sn, Tl, U, V and W in human blood. The laboratory validation was organized so as to vary the most representative factors (operators, time, materials, instrumental settings, calibrations) that could affect the analytical data. Then, only those sources that significantly affected the final result were considered in the uncertainty estimate, simplifying so the process. Validation data in blood were: linearity, R2 > 0.9992 over two orders of concentration; detection limits between 0.0015 μg L-1 - 1.03 μg L-1; mean trueness on certified reference materials between 91.2%-109.6%; mean recovery on spikes ranging 92%-105%; repeatability from 3.0% to 6.3% and reproducibility from 3.8% to 9.2%. The expanded uncertainty budget derived from two sources (reproducibility and trueness/recovery) was between 11% and 26%. Applying the proposed procedure in future biomonitoring studies for metals exposure will allow the production of analytical data of high quality and reliability. This is also crucial to correctly interpret the biomonitoring data with respect to statutory limits, reference limits and measures produced by other laboratories.
Keywords: Method validation, Uncertainty estimation, Metals, Human blood, Biomonitoring, SF-ICP-MS, Limit of detection, Limit of quantification, Multi-point calibration, Calibration Parameters, TRP modulators for pain indications, inflammatory and neuropathic pain, urinary incontinence, painful bladder syndrome, prostate cancer
Current Analytical Chemistry
Title: Monitoring of Environmental Metals in Human Blood: The Need for Data Validation
Volume: 7 Issue: 4
Author(s): Beatrice Bocca, Daniela Mattei, Anna Pino and Alessandro Alimonti
Affiliation:
Keywords: Method validation, Uncertainty estimation, Metals, Human blood, Biomonitoring, SF-ICP-MS, Limit of detection, Limit of quantification, Multi-point calibration, Calibration Parameters, TRP modulators for pain indications, inflammatory and neuropathic pain, urinary incontinence, painful bladder syndrome, prostate cancer
Abstract: Human biomonitoring results can be used to evaluate prior metals exposures but the data production must adhere to rigorous scientific standards including validation of the analytical method and calculation of the methods uncertainty. The whole procedure is often perceived as a difficult and time-consuming task. The aim of this paper was to in house validate a sector field inductively coupled plasma mass spectrometry-based method and to speed up the calculation of measurements uncertainty in the monitoring of As, Be, Cd, Co, Cr, Hg, Ir, Mn, Mo, Ni, Pb, Pd, Pt, Rh, Sb, Sn, Tl, U, V and W in human blood. The laboratory validation was organized so as to vary the most representative factors (operators, time, materials, instrumental settings, calibrations) that could affect the analytical data. Then, only those sources that significantly affected the final result were considered in the uncertainty estimate, simplifying so the process. Validation data in blood were: linearity, R2 > 0.9992 over two orders of concentration; detection limits between 0.0015 μg L-1 - 1.03 μg L-1; mean trueness on certified reference materials between 91.2%-109.6%; mean recovery on spikes ranging 92%-105%; repeatability from 3.0% to 6.3% and reproducibility from 3.8% to 9.2%. The expanded uncertainty budget derived from two sources (reproducibility and trueness/recovery) was between 11% and 26%. Applying the proposed procedure in future biomonitoring studies for metals exposure will allow the production of analytical data of high quality and reliability. This is also crucial to correctly interpret the biomonitoring data with respect to statutory limits, reference limits and measures produced by other laboratories.
Export Options
About this article
Cite this article as:
Bocca Beatrice, Mattei Daniela, Pino Anna and Alimonti Alessandro, Monitoring of Environmental Metals in Human Blood: The Need for Data Validation, Current Analytical Chemistry 2011; 7 (4) . https://dx.doi.org/10.2174/157341111797183119
DOI https://dx.doi.org/10.2174/157341111797183119 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
Call for Papers in Thematic Issues
Advancements in biomedicine, corrosion inhibition/monitoring, and lubrication of carbon dots
Carbon dots, a class of carbon-based nanomaterials, have garnered substantial interest in various scientific and engineering fields due to their unique properties, including excellent optical properties, outstanding biocompatibility, easy preparation, good dispersity, ultrasmall size, low toxicity and environmental friendliness. This special issue of Current Analytical Chemistry aims to showcase cutting-edge ...read more
Advances in Microfluidic and Sensing Technologies of Biofluids.
Detection of biological fluids is an important means to assess human health and diagnose diseases. Currently, research on blood is relatively mature and widely applied in the medical field. With the development and advancement of microfluidic technology and novel detection methods, attention has turned to human physiological fluids such as ...read more
Analytical methods for environmental and food analysis
In recent years, the study of the chemical composition of food and the environment depends on analytical methods in order to acquire information about the chemical composition, processing, quality control and contamination of soil, water, air, plants and foods, aspects very important for food safety and environmental quality control. There ...read more
Applications of artificial intelligence in chemical analysis
Artificial intelligence (AI) has demonstrated its versatility in almost all scientific fields, especially analytical chemistry, which is leading the way in the integration of AI. According to Chemical Abstract Services, one of the major disciplines contributing to AI-related publications and patents is analytical chemistry. That?s because techniques such as deep ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanoparticle Based Delivery of Protease Inhibitors to Cancer Cells
Current Medicinal Chemistry Tissue Elasticity Bridges Cancer Stem Cells to the Tumor Microenvironment Through microRNAs: Implications for a “Watch-and-Wait” Approach to Cancer
Current Stem Cell Research & Therapy Editorial [Hot Topic: Transcriptomic Biomarkers in Cancer Diagnosis, Prognosis and Therapy Monitoring (Guest Editor: Monica Neagu)]
Recent Patents on Biomarkers Antigenic Peptide Vaccination: Provoking Immune Response and Clinical Benefit for Cancer
Current Immunology Reviews (Discontinued) Newly Identified Tumor Antigens as Promising Cancer Vaccine Targets for Malignant Melanoma Treatment
Current Topics in Medicinal Chemistry Chemical Consequences of Radioactive Decay and their Biological Implications
Current Radiopharmaceuticals Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology LncRNA HOTAIR as Prognostic Circulating Marker and Potential Therapeutic Target in Patients with Tumor Diseases
Current Drug Targets Radionuclides Used in Nuclear Medicine Therapy – From Production to Dosimetry
Current Medical Imaging Inflammatory Cytokines Pathways as Potential Therapeutic Targets for Gastric Cancer
Current Cancer Therapy Reviews Targeting Indoleamine 2,3-dioxygenase (IDO) to Counteract Tumour- Induced ImmuneDysfunction: From Biochemistry to Clinical Development
Endocrine, Metabolic & Immune Disorders - Drug Targets Obesity-Driven Inflammation and Colorectal Cancer
Current Medicinal Chemistry Regulation of EMT by KLF4 in Gastrointestinal Cancer
Current Cancer Drug Targets Multi-Targeted Histone Deacetylase Inhibitors in Cancer Therapy
Current Medicinal Chemistry Phytocannabinoids and Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Evaluation of Multifunctional Hybrid Analogs for Stilbenes, Chalcones and Flavanones
Anti-Cancer Agents in Medicinal Chemistry Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials
Current Cancer Drug Targets Recent Patents on Devices and Technologies for Early Cancer Diagnostics
Recent Patents on Biomedical Engineering (Discontinued) Ensemble of G Protein-Coupled Receptor Active States
Current Medicinal Chemistry Methods to Access 2-aminobenzimidazoles of Medicinal Importance
Current Organic Chemistry